• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解多囊肾病所开药物、饮食及生活方式治疗的障碍。

Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease.

作者信息

Tran Wen-Ching, Huynh David, Chan Tea, Chesla Catherine A, Park Meyeon

机构信息

School of Medicine, University of California, San Francisco, CA, USA.

Division of Nephrology, Department of Medicine, University of California, 521 Parnassus Ave, C443, Box 0532, San Francisco, CA, 94143, USA.

出版信息

BMC Nephrol. 2017 Jul 5;18(1):214. doi: 10.1186/s12882-017-0641-3.

DOI:10.1186/s12882-017-0641-3
PMID:28679364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5498983/
Abstract

BACKGROUND

Autosomal dominant polycystic kidney disease (PKD) is the most common genetic renal disease and the fourth leading cause of end-stage renal disease in the United States. Although there is no cure for PKD, several treatments are considered to be beneficial, including blood pressure control, exercise, low-salt diet, and high volume water intake. However, levels of understanding of the importance of these treatments and adherence to these recommendations vary among patients. This study explores illness perception models of patients with PKD to reveal barriers in adherence to prescribed therapies; satisfaction with medical care; and sources of medical information.

METHODS

We designed a phenomenological interview study to evaluate illness perception models of individuals with PKD. Patients were identified from the national PKD Foundation e-mail distribution list (N = 190) and responded voluntarily to an introductory survey (N = 50). Seventeen PKD patients in the Bay Area were scheduled for one-on-one in-depth interviews with one trained interviewer (W-CT). Open-ended questions administered with an interview guide were used to evaluate patients' beliefs.

RESULTS

Mean age was 56.6 +/- 12 years (range 29-78); 65% were female. Many of the PKD patients in this study were highly motivated and willing to incorporate blood pressure, exercise, low-salt diet, and high volume water intake into their daily routines. Barriers to adherence to these therapies include personal beliefs and confusion due to unclear recommendations.

CONCLUSIONS

These findings suggest there is variability between what patients understand about their disease and treatments and what they believe their doctors have told them. Not all physicians focus on lifestyle-based treatments, but the majority of PKD patients in our study are motivated and willing to incorporate blood pressure control, exercise, low-salt diet, and high volume water intake into their daily routines and would like specific recommendations on how to implement these. These findings support a role for further exploring patient beliefs about the disease and its necessary treatments in order to design strategies to improve communication and meet the needs of these patients.

摘要

背景

常染色体显性多囊肾病(PKD)是最常见的遗传性肾病,在美国是终末期肾病的第四大主要病因。虽然PKD无法治愈,但几种治疗方法被认为有益,包括控制血压、运动、低盐饮食和大量饮水。然而,患者对这些治疗重要性的理解程度以及对这些建议的依从性各不相同。本研究探讨PKD患者的疾病认知模式,以揭示在遵循规定治疗方面的障碍、对医疗护理的满意度以及医疗信息来源。

方法

我们设计了一项现象学访谈研究,以评估PKD患者的疾病认知模式。从全国PKD基金会电子邮件分发列表中识别出患者(N = 190),并自愿回复一份初步调查问卷(N = 50)。安排了旧金山湾区的17名PKD患者与一名经过培训的访谈者(W - CT)进行一对一深度访谈。使用访谈指南中的开放式问题来评估患者的信念。

结果

平均年龄为56.6±12岁(范围29 - 78岁);65%为女性。本研究中的许多PKD患者积极性很高,愿意将控制血压、运动、低盐饮食和大量饮水纳入日常生活。遵循这些治疗的障碍包括个人信念以及因建议不明确而产生的困惑。

结论

这些发现表明,患者对自身疾病和治疗的理解与他们认为医生告知他们的内容之间存在差异。并非所有医生都关注基于生活方式的治疗,但我们研究中的大多数PKD患者积极性很高,愿意将控制血压、运动、低盐饮食和大量饮水纳入日常生活,并希望获得关于如何实施这些措施的具体建议。这些发现支持进一步探索患者对疾病及其必要治疗的信念,以便设计改善沟通并满足这些患者需求的策略。

相似文献

1
Understanding barriers to medication, dietary, and lifestyle treatments prescribed in polycystic kidney disease.了解多囊肾病所开药物、饮食及生活方式治疗的障碍。
BMC Nephrol. 2017 Jul 5;18(1):214. doi: 10.1186/s12882-017-0641-3.
2
What are the information needs and concerns of individuals with Polycystic Kidney Disease? Results of an online survey using Facebook and social listening analysis.多囊肾病患者的信息需求和关注点是什么?使用 Facebook 和社会倾听分析的在线调查结果。
BMC Nephrol. 2021 Jul 14;22(1):263. doi: 10.1186/s12882-021-02472-1.
3
Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.预防和控制高血压的生活方式改变。5. 关于膳食盐的建议。加拿大高血压协会、加拿大高血压预防与控制联盟、加拿大卫生部疾病控制实验室中心、加拿大心脏与中风基金会。
CMAJ. 1999 May 4;160(9 Suppl):S29-34.
4
[Clinical practice guidelines for polycystic kidney diseases].[多囊肾病临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):277-283. doi: 10.3760/cma.j.issn.1003-9406.2020.03.009.
5
Can progression of autosomal dominant or autosomal recessive polycystic kidney disease be prevented?常染色体显性或常染色体隐性多囊肾病的进展能够被阻止吗?
Semin Nephrol. 2001 Sep;21(5):430-40. doi: 10.1053/snep.2001.24937.
6
Polycystic kidney disease in the first year of life.出生后第一年的多囊肾病。
J Pediatr. 1987 Nov;111(5):693-9. doi: 10.1016/s0022-3476(87)80244-5.
7
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.盐摄入对高血压发病机制及治疗的影响
Adv Exp Med Biol. 2017;956:61-84. doi: 10.1007/5584_2016_147.
8
An exploration of the relationship between adherence with dietary sodium restrictions and health beliefs regarding these restrictions in Irish patients receiving haemodialysis for end-stage renal disease.探讨爱尔兰终末期肾病血液透析患者对饮食钠限制的依从性与健康信念之间的关系。
J Clin Nurs. 2011 Feb;20(3-4):331-40. doi: 10.1111/j.1365-2702.2010.03348.x.
9
Optimising the management of polycystic kidney disease.优化多囊肾病的管理
Practitioner. 2016 Feb;260(1790):13-6, 2.
10
The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations.“总理干预措施”帮助参与者遵循“终止高血压膳食方法”饮食模式以及当前的膳食参考摄入量建议。
J Am Diet Assoc. 2007 Sep;107(9):1541-51. doi: 10.1016/j.jada.2007.06.019.

引用本文的文献

1
Participant Perceptions of Increasing Water Intake in Polycystic Kidney Disease.多囊肾病患者对增加饮水量的认知
Kidney Int Rep. 2025 Apr 27;10(7):2265-2274. doi: 10.1016/j.ekir.2025.04.041. eCollection 2025 Jul.
2
Harnessing Social Media Data to Understand Information Needs About Kidney Diseases and Emotional Experiences With Disease Management: Topic and Sentiment Analysis.利用社交媒体数据了解肾脏疾病的信息需求及疾病管理中的情感体验:主题与情感分析
J Med Internet Res. 2025 Feb 25;27:e64838. doi: 10.2196/64838.
3
Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病长期临床试验中的参与者认知
Kidney Med. 2023 Jun 29;5(9):100691. doi: 10.1016/j.xkme.2023.100691. eCollection 2023 Sep.
4
Health Disparities in Kidney Failure Among Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional Study.常染色体显性多囊肾病患者肾衰竭中的健康差异:一项横断面研究。
Kidney Med. 2022 Dec 5;5(2):100577. doi: 10.1016/j.xkme.2022.100577. eCollection 2023 Feb.
5
What are the information needs and concerns of individuals with Polycystic Kidney Disease? Results of an online survey using Facebook and social listening analysis.多囊肾病患者的信息需求和关注点是什么?使用 Facebook 和社会倾听分析的在线调查结果。
BMC Nephrol. 2021 Jul 14;22(1):263. doi: 10.1186/s12882-021-02472-1.
6
Salt-deficient diet exacerbates cystogenesis in ARPKD via epithelial sodium channel (ENaC).低盐饮食通过上皮钠通道(ENaC)加剧 ARPKD 的囊肿生成。
EBioMedicine. 2019 Feb;40:663-674. doi: 10.1016/j.ebiom.2019.01.006. Epub 2019 Feb 8.

本文引用的文献

1
System-Level Barriers and Facilitators for Foregoing or Withdrawing Dialysis: A Qualitative Study of Nephrologists in the United States and England.放弃或停止透析的系统层面障碍与促进因素:对美国和英国肾病学家的定性研究
Am J Kidney Dis. 2017 Nov;70(5):602-610. doi: 10.1053/j.ajkd.2016.12.015. Epub 2017 Feb 24.
2
A systematic review to determine the most effective interventions to increase water intake.一项旨在确定增加饮水量最有效的干预措施的系统评价。
Nephrology (Carlton). 2016 Oct;21(10):860-9. doi: 10.1111/nep.12675.
3
Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians.了解早期常染色体显性多囊肾病的身体和情感影响:患者及医生的经历与观点
Clin Kidney J. 2015 Oct;8(5):531-7. doi: 10.1093/ckj/sfv060. Epub 2015 Jul 28.
4
Predictors of self-reported adherence to antihypertensive medicines: a multinational, cross-sectional survey.自我报告的抗高血压药物依从性的预测因素:一项跨国横断面调查。
Value Health. 2015 Mar;18(2):206-16. doi: 10.1016/j.jval.2014.12.013.
5
Dietary sodium and health: more than just blood pressure.膳食钠与健康:不止关乎血压。
J Am Coll Cardiol. 2015 Mar 17;65(10):1042-50. doi: 10.1016/j.jacc.2014.12.039.
6
Blood pressure in early autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病早期的血压情况
N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15.
7
The medicinal use of water in renal disease.水在肾病中的药用。
Kidney Int. 2013 Jul;84(1):45-53. doi: 10.1038/ki.2013.23. Epub 2013 Feb 20.
8
Tolvaptan in patients with autosomal dominant polycystic kidney disease.托伐普坦治疗常染色体显性遗传多囊肾病。
N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3.
9
Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.预防心血管疾病药物的依从性:对 376,162 名患者的荟萃分析。
Am J Med. 2012 Sep;125(9):882-7.e1. doi: 10.1016/j.amjmed.2011.12.013. Epub 2012 Jun 27.
10
Water prescription in autosomal dominant polycystic kidney disease: a pilot study.常染色体显性多囊肾病的水液处方:一项初步研究。
Clin J Am Soc Nephrol. 2011 Jan;6(1):192-7. doi: 10.2215/CJN.03950510. Epub 2010 Sep 28.